AKT1 and non-small cell lung carcinoma: In vitro studies have shown that NEK2 promotes cell proliferation by AKT and Wnt activation in NSCLC [45] and hepatocellular carcinoma [46] and via ERK/MAPK (extracellular signal-regulated kinase/mitogen-activated protein kinase) signaling in gastric cancer [47].